Wednesday, October 21, 2026
25.3 C
Bengaluru

Has Indian Pharma Seen The Longevity Tsunami Coming?

Why India Must Urgently Reinvent Healthcare for a 100-Year Life — And How Pharma Can Lead the Charge

India is entering a longevity era unlike anything in its history. New global data shows the rise of centenarians is no longer a fringe trend—it’s a demographic wave gaining unstoppable velocity. Japan leads with 123,330 centenarians, followed by the U.S. (73,629), China (48,566), and India ranks fourth with 37,988 according to recent global estimates [1].

People are living longer due to better healthcare access, improved living standards, and stronger disease-management ecosystems [2]. But as lifespans stretch, the cracks in India’s health and social systems are widening fast.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

Anuj Pasrija has been elevated to Country Lead, Johnson...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

With over two decades of experience across finance, strategy,...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of...
spot_img

Related Articles

spot_imgspot_img